EVAX (Evaxion AS) 6-Month Price Index: 0.87 (As of Sep. 11, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

EVAX Evaxion AS EVAX
52 GF Score
Price $3.13
GF Value $3.34
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Evaxion AS 6-Month Price Index?

Evaxion AS EVAX -5.20% 52 6-Month Price Index is 0.87 as of Sep. 11, 2026. GuruFocus rates EVAX with a GF Score™ of 52/100 and a GF Value™ of $3.34 (Fairly Valued). The stock has 1 warning sign investors should review.

6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. It’s calculated by current share price divided by share price 6-months ago. As of today (2026-09-11), Evaxion AS's 6-Month Price Index is 0.87.

Evaxion AS  (NAS:EVAX) 6-Month Price Index Explanation

Price Index (PI) also called momentum. Strategies involving Price Index are also known as momentum strategies as they allow investors to profit from a company’s stock price. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago.

The investment strategy for momentum investors is to buy winners and sell losers. That is, buy stocks that performed well and sell stocks that performed poorly in the past.

Evaxion AS 6-Month Price Index Related Terms

EVAX vs DYAI, ATOS, PVCT: 6-Month Price Index Comparison

For the Biotechnology subindustry, Evaxion AS's 6-Month Price Index, along with its competitors' market caps and 6-Month Price Index data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

EVAX
52GF Score
Evaxion AS EVAX
6-Month Price Index is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Evaxion AS  (NAS:EVAX) 6-Month Price Index Calculation

6-Month Price Index is calculated as following:

6-Month Price Index=Current Share Price / Share Price 6-Months Ago

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 6-Month Price Index →
What does a 6-Month Price Index of 0.87 mean?
Evaxion AS (EVAX) has a 6-Month Price Index of 0.87 as of Sep. 11, 2026. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. View historical data on Evaxion AS and its competitors.
Is Evaxion AS's 6-Month Price Index too high?
Evaxion AS's current 6-Month Price Index is 0.87. Overall, Evaxion AS has a GF Score™ of 52/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Evaxion AS's 6-Month Price Index compare to DYAI and ATOS?
Evaxion AS's 6-Month Price Index of 0.87 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 6-Month Price Index for a Biotechnology company?
A good 6-Month Price Index depends on the Biotechnology industry context. However, 6-Month Price Index should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 6-Month Price Index mean?
A high 6-Month Price Index can signal that a stock is expensive relative to its fundamentals. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. View historical data on Evaxion AS and its competitors. Evaxion AS's current 6-Month Price Index is 0.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evaxion AS stock overvalued right now?
Based on GuruFocus' analysis, Evaxion AS (EVAX) is currently considered Fairly Valued. The stock's GF Value™ is $3.34, compared to a current price of $3.13 — trading 6.4% below its estimated fair value. The current 6-Month Price Index is 0.87. Evaxion AS's overall GF Score™ is 52/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 6-Month Price Index calculated?
6-Month Price Index is calculated from a company's financial statements. For Evaxion AS (EVAX), the current 6-Month Price Index is 0.87 as of Sep. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Evaxion AS (EVAX) Overvalued in 2026?

Based on GuruFocus' analysis, Evaxion AS stock appears to be undervalued. The current stock price of $3.13 is trading 6.4% below its estimated GF Value™ of $3.34. GuruFocus considers Evaxion AS to be Fairly Valued.

Key valuation signals for EVAX:

  • 6-Month Price Index: 0.87
  • GF Value™: $3.34 vs. price of $3.13 (6.4% below fair value)
  • GF Score™: 52/100 with 1 warning sign

No single metric tells the full story. See the EVAX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Evaxion AS Business Description

Address Dr. Neergaards Vej 5f, Horsholm, DNK, 2970
Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.
52GF Score

Get the complete analysis for EVAX

6-Month Price Index is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.13
Price
$3.34
GF Value